CSL Stock Price, News & Analysis (ASX:CSL) Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume869,289 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.37%Price TargetN/A About CSL Stock (ASX:CSL)CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.Read More CSL Stock News HeadlinesDecember 5, 2023 | bizjournals.comCSL Plasma awarded $5M judgment against Boca Raton advertising agencyDecember 5, 2023 | finance.yahoo.comReNAgade Therapeutics Appoints Paul Perreault to Board of DirectorsDecember 5, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comDecember 5, 2023 | finance.yahoo.comComEd, CSL Highlight Completion of New Electrical Substation to Serve Kankakee Plant, Support Continued Regional Economic GrowthDecember 5, 2023 | fool.com.auCSL shares up 15% in 5 weeks amid two hedge funds placing opposing betsDecember 3, 2023 | msn.com‘The sky’s the limit’: can Saudi Arabian football pull off what China failed to do?December 1, 2023 | msn.comBMW M2 CS Coming In 2025 With No Manual TransmissionNovember 29, 2023 | fool.com.auCould CSL stock be a millionaire-maker at $261December 5, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 28, 2023 | businesswire.comJapan's Ministry of Health, Labour and Welfare Approves CSL and Arcturus Therapeutics’ ARCT-154, the First Self-Amplifying mRNA Vaccine Approved for COVID in AdultsNovember 27, 2023 | msn.comFrom bidding for Bale to selling the team bus - the fall of the CSLNovember 26, 2023 | msn.com1-of-50 2023 BMW 3.0 CSL Made Someone Splurge at RM Sotheby’s Munich AuctionNovember 25, 2023 | msn.comThe Fanatec sim racing power upgrade I've been ever-so-tempted to buy for over a year has $150 off for Black FridayNovember 23, 2023 | finance.yahoo.comIs Carlisle Companies Incorporated's (NYSE:CSL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?November 21, 2023 | msn.comAre haemophilia gene therapies truly “one and done”?November 21, 2023 | afr.comMelbourne earns top marks for researchNovember 21, 2023 | fool.com.auWhat's the outlook for CSL shares in 2024?November 17, 2023 | seekingalpha.comCSL Limited: Positive Capital Return And Earnings Growth ExpectationsNovember 17, 2023 | msn.comM Performance Adds 3.0 CSL Flair To BMW M2 And M3November 14, 2023 | fool.com.auWhy has Goldman Sachs just upgraded CSL shares?November 14, 2023 | msn.comWhat to Know About Donating Plasma for MoneyNovember 14, 2023 | finance.yahoo.comCarlisle Companies Commits to Largest Purse in Epson Tour History, with a Three-Year ExtensionNovember 13, 2023 | msn.comThree unloved sectors (and 5 stocks) that could become tomorrow’s winnersNovember 13, 2023 | fool.com.auCSL share price correction! Timely chance to buy the dip?November 13, 2023 | msn.com1 Of 50 BMW 3.0 CSLs Is Already Looking For A New HomeNovember 10, 2023 | msn.comAussies unprepared for nastier summer bites and stingsNovember 10, 2023 | msn.comMotorious Readers Get Double Entries To Win This BMW M4 CSL and BMW MotorcycleSee More Headlines Receive CSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2019Ex-Dividend for 10/3 Dividend9/10/2023Dividend Payable10/03/2023Today12/05/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolASX:CSL CUSIPN/A CIKN/A Webwww.csl.com.au Phone+61-3-93891911FaxN/AEmployees32,065Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$6.76 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.29Net Income$2.19 billion Net Margins16.48% Pretax MarginN/A Return on Equity13.85% Return on Assets6.30% Debt Debt-to-Equity Ratio68.59 Current Ratio2.01 Quick Ratio1.68 Sales & Book Value Annual Sales$13.31 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.70 Book ValueA$32.73 per share Price / BookN/AMiscellaneous Outstanding Shares483,060,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.27 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesDr. Paul F. McKenzie Ph.D. (Age 57)MD, CEO & Executive Director Comp: $4.19MMs. Joy Carolyn Linton B.Com. (Age 58)BComm, GAICD, Grad Dip AFI, Chief Financial Officer Comp: $3.12MMr. Mark DehringHead of Investor RelationsMr. Gregory Boss B.S. (Age 62)BS(Hons), J.D., Executive VP of Legal & General Counsel Comp: $1.67MChristina HickieSenior Manager of CommunicationsDr. Karen Etchberger (Age 65)Executive Vice President of Quality & Business Services Comp: $1.57MMs. Jemimah BrennanHead of Communications - Asia PacificMr. William Campbell B.S. (Age 63)Executive VP & Chief Commercial Officer Comp: $1.85MDr. Andrew D. Nash (Age 61)Senior Vice President of Research Dr. William Mezzanotte M.D. (Age 64)M.P.H., Executive VP & Head of Research and Development Comp: $2.22MMore ExecutivesKey Competitors3SBioOTCMKTS:TRSBF45525 (CUR.TO)TSE:CUR60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAbzenaLON:ABZAView All CompetitorsInsidersMegan ClarkBought 210 shares on 10/20/2023Total: $49,939.05 ($237.81/share)Paul McKenzieSold 44,095 sharesTotal: $10.51 M ($238.24/share)Paul McKenzieSold 3,120 sharesTotal: $839,560.80 ($269.09/share)Robert CuthbertsonSold 20,000 sharesTotal: $5.31 M ($265.55/share)Marie McDonaldSold 290 sharesTotal: $79,002.96 ($272.42/share) CSL Stock Analysis - Frequently Asked Questions How were CSL's earnings last quarter? CSL Limited (ASX:CSL) issued its quarterly earnings results on Wednesday, August, 14th. The company reported $4.24 earnings per share for the quarter, topping the consensus estimate of $4.22 by $0.01. CSL had a trailing twelve-month return on equity of 13.85% and a net margin of 16.48%. How often does CSL pay dividends? What is the dividend yield for CSL? CSL declared a Final dividend on Thursday, September 7th. Stockholders of record on Tuesday, October 3rd will be paid a dividend of 1.992 per share on Tuesday, October 3rd. This represents a dividend yield of 0.74%. The ex-dividend date is Sunday, September 10th. This is a positive change from the stock's previous Final dividend of A$1.61. Read our dividend analysis for CSL. Is CSL a good dividend stock? CSL (ASX:CSL) pays an annual dividend of A$3.63 per share and currently has a dividend yield of 1.37%. The dividend payout ratio is 53.70%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for CSL. What other stocks do shareholders of CSL own? Based on aggregate information from My MarketBeat watchlists, some companies that other CSL investors own include BHP Group (BHP), Commonwealth Bank of Australia (CBA), Cochlear (COH), ResMed (RMD), Telstra Group (TLS), Woodside Petroleum (WPL), Altium (ALU), Afterpay (APT), Appen (APX) and Berkshire Hathaway (BRK.B). This page (ASX:CSL) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.